New hope against superbugs: gut cleanse trial launches
Disease control
ENROLLING_BY_INVITATION
This study tests a treatment called BM111 to remove two types of drug-resistant bacteria (CRE and VRE) from the gut of healthy carriers. About 38 adults who carry these bacteria but don't have an active infection will receive BM111 or a placebo. The goal is to see if BM111 can sa…
Phase: NA • Sponsor: BioMe Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC